Status
Conditions
Treatments
About
The proposed study will predict a patients' risk of having osteoporosis by using a combination of the IBEX BH (Bone Health) software outputs and other clinical risk factors such as age, gender, medical history and lifestyle. A comparison will be made between the IBEX BH prediction and the one calculated in current clinical practice using a tool called FRAX (Fracture Risk Assessment Tool) which combines clinical risk factors with results from a Dual Energy X-ray Absorptiometry (DXA) assessment.
The study involves conducting these assessments on several new anatomies including Knee, Ankle and Pelvis, to extend the market reach and clinical utility of IBEX BH. The expected outcome of the study is that the IBEX BH will offer better decision support to clinicians in terms of referral on for a DXA scan or osteoporosis investigations than available today.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
For the collection of test data in the study.
Inclusion Criteria:
Exclusion Criteria:
For the collection of healthy-normal data in the study.
Inclusion Criteria:
Exclusion Criteria:
Loading...
Central trial contact
Robert Meertens, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal